// App-Quantinova.ai

P6.372 : Comparative analysis of MS outcomes in dimethyl fumarate-treated patients relative to propensity matched fingolimod, interferon, glatiramer acetate, or teriflunomide (P6.372)

Researchers

Presenter

  • Timothy Spelman

Principal Investigators

  • Maria Trojana

  • Francois Grand-Maison

  • Guillermo Izquierdo

  • Eva Havrdova

  • Dana Horakova

  • Alessandra Lugaresi

  • Pierre Duquette

  • Pierre Grammond

  • Raymond Hupperts

  • Jeannette Lechner-Scott

  • Franco Granella

  • Thor Petersen

  • Murat Terzi

  • Eugenio Pucci

  • Patrizia Sola

  • Vincent Van Pesch

  • Gerardo Iuliano

  • Cavit Boz

  • Roberto Bergamaschi

  • Mark Slee

  • Helmut Butzkueven

Medical Centers

  • 4Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague Prague Czech Republic

  • 11Neurology Unit, ASUR Marche – AV3 Macerata Italy

  • 2Department of Medicine and Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne Parkville Australia

  • IRCCSIstituto delle Scienze Neurologiche di Bologna, Bologna, Italy

  • Department of Neuroscience, University of Padua, Padua, Italy

  • Department of Neuroscience, Neurology Unit, Nuovo Ospedale Civile S. Agostino-Estense Modena Italy

  • John Hunter Hospital, Newcastle, Australia

  • Kommunehospitalet Aarhus Denmark

  • 19 Mayis Universitesi Samsun Turkey

  • Flinders University Medical Centre, Adelaide, Australia

  • Medical Faculty Farabi Hospital, Karadeniz Technical University Trabzon Turkey

  • 9Hôpital Notre Dame Montreal QC Canada

  • Hospital Universitario Virgen del Rocio, Sevilla, Spain

  • Department of Biomedical and Neuromotor Sciences, University of Bologna Italy, Bologna, Italy

  • 20Maaslandziekenhuis Sittard Netherlands

  • Department of Basic Medical Sciences, Neurosciences and Sense Organs University of Bari, Italy, Bari, Italy

  • 8Center de réadaptation déficience physique Chaudière-Appalache Lévis QC Canada

  • 16Neuro Rive-Sud, Hôpital Charles LeMoyne Greenfield Park QC Canada

  • 11Neurological Institute IRCCS Mondino Bari Italy

  • Melbourne Brain Centre and Department of Medicine at the Royal Melbourne Hospital, University of Melbourne Melbourne Australia

  • Ospedali Riuniti di Salerno Salerno Italy

  • Cliniques Universitaires Saint-Luc, UCL, Brussels, MN, Belgium

  • 4Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague Prague Czech Republic

Locations

  • Italy

  • Australia

  • Denmark

  • Turkey

  • Canada

  • Spain

  • Netherlands

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • glatiramer

  • Dimethyl fumarate

  • Teriflunomide

  • Fingolimod

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved